BioInsights - Home page

CELL AND GENE THERAPY INSIGHTS

August 2023 Issue

Vol 9 Issue 7

New horizons in immunotherapy

Featuring this month's spotlight content:

New horizons in immunotherapy
View
Driving the digitization of cell and gene therapy supply chains

Supply Chain focus:

Driving the digitization of cell and gene therapy supply chains
View
Cell and Gene Therapy Insights Vol 9 Issue 7
View

Upcoming webinars

Alleviating production bottlenecks in AAV manufacture via platform innovation

Alleviating production bottlenecks in AAV manufacture via platform innovation

Weiheng Su, Matt Roach
3 October
in 1
Day
Register
The growing case for stainless steel versus single-use in mRNA vaccine production

The growing case for stainless steel versus single-use in mRNA vaccine production

Steve Attig
4 October
in 2
Days
Register
Cell sorting for enrichment of neuronal subpopulations – new perspectives for clinical research

Cell sorting for enrichment of neuronal subpopulations – new perspectives for clinical research

Thomas Andreska, E Nent, C Jin
5 October
in 3
Days
Register
Case study: becoming the first GMP-certified cell and gene therapy manufacturing facility in Thailand

Case study: becoming the first GMP-certified cell and gene therapy manufacturing facility in Thailand

Kitipong Uaesoontrachoon
10 October
in 8
Days
Register
Live lab demo: unlock the future of vaccine analysis with CTech SoloVPE

Live lab demo: unlock the future of vaccine analysis with CTech SoloVPE

Paul Mania, Nigel Herbert
11 October
in 9
Days
Register
New empty/full method to enable robust manufacturing of AAV products

New empty/full method to enable robust manufacturing of AAV products

Aleš Štrancar
12 October
in 10
Days
Register
View all webinars

Latest Articles

How to expedite clinical development of oncology agents: overcoming complexities of early-phase oncology trials for ATMPs

How to expedite clinical development of oncology agents: overcoming complexities of early-phase oncology trials for ATMPs

Harriet Gray Stephens
29 September
Viewpoint
Early-stage considerations for accelerating cell and gene therapy commercialization

Early-stage considerations for accelerating cell and gene therapy commercialization

Sabrina Carmichael
29 September
Innovator Insight
Current trends in ATMPs

Current trends in ATMPs

Helena Strigard, Jonathan Royce
28 September
Conference Insight
Addressing the risk presented by extractables and leachables in cell therapy manufacturing

Addressing the risk presented by extractables and leachables in cell therapy manufacturing

Jason Creasey
28 September
Interview
High-throughput process & analytical platforms to accelerate gene therapy scale-up

High-throughput process & analytical platforms to accelerate gene therapy scale-up

P Starremans, K Warrington, N Jesuraj
28 September
Innovator Insight
Utilizing an automation-on-demand analytical tool for cancer immunotherapy

Utilizing an automation-on-demand analytical tool for cancer immunotherapy

Christoph Eberle
22 September
Innovator Insight
How to achieve both cost and quality goals in plasmid manufacturing

How to achieve both cost and quality goals in plasmid manufacturing

Silvia Orsini
22 September
FastFacts
Quality by design planning in ATMPs: standards for manufacturers

Quality by design planning in ATMPs: standards for manufacturers

Matthew Chorley
22 September
FastFacts
Analyzing lentivirus particles using dPCR techniques

Analyzing lentivirus particles using dPCR techniques

Samyuktha Shankar
21 September
FastFacts

Channel content

Early-stage considerations for accelerating cell and gene therapy commercialization

Early-stage considerations for accelerating cell and gene therapy commercialization

Sabrina Carmichael
29 September
Innovator Insight
High-throughput process & analytical platforms to accelerate gene therapy scale-up

High-throughput process & analytical platforms to accelerate gene therapy scale-up

P Starremans, K Warrington, N Jesuraj
28 September
Innovator Insight
How to achieve both cost and quality goals in plasmid manufacturing

How to achieve both cost and quality goals in plasmid manufacturing

Silvia Orsini
22 September
FastFacts
View channel
High-throughput process & analytical platforms to accelerate gene therapy scale-up

High-throughput process & analytical platforms to accelerate gene therapy scale-up

P Starremans, K Warrington, N Jesuraj
28 September
Innovator Insight
How to achieve both cost and quality goals in plasmid manufacturing

How to achieve both cost and quality goals in plasmid manufacturing

Silvia Orsini
22 September
FastFacts
Quality by design planning in ATMPs: standards for manufacturers

Quality by design planning in ATMPs: standards for manufacturers

Matthew Chorley
22 September
FastFacts
View channel
Early-stage considerations for accelerating cell and gene therapy commercialization

Early-stage considerations for accelerating cell and gene therapy commercialization

Sabrina Carmichael
29 September
Innovator Insight
High-throughput process & analytical platforms to accelerate gene therapy scale-up

High-throughput process & analytical platforms to accelerate gene therapy scale-up

P Starremans, K Warrington, N Jesuraj
28 September
Innovator Insight
Overcoming the challenge of antiviral defense in viral vector manufacturing

Overcoming the challenge of antiviral defense in viral vector manufacturing

Jean-Simon Diallo, Jondavid De Jong
21 September
Interview
View channel
How to expedite clinical development of oncology agents: overcoming complexities of early-phase oncology trials for ATMPs

How to expedite clinical development of oncology agents: overcoming complexities of early-phase oncology trials for ATMPs

Harriet Gray Stephens
29 September
Viewpoint
Regulatory considerations & validation strategies for mycoplasma testing for cell-based therapies

Regulatory considerations & validation strategies for mycoplasma testing for cell-based therapies

Michael Brewer
14 September
Innovator Insight
Identifying and leveraging viral vector critical quality attributes & critical process parameters using process analytical technologies

Identifying and leveraging viral vector critical quality attributes & critical process parameters using process analytical technologies

Jonathan Appleby, John Churchwell
24 August
Interview
View channel
Cell and gene therapy commercial off-the-shelf software components

Cell and gene therapy commercial off-the-shelf software components

Parris Farr
23 August
Commentary
The supporting role of plasmids in gene & cell therapy

The supporting role of plasmids in gene & cell therapy

Duarte Prazeres
6 July
Expert Insight
View channel
How to expedite clinical development of oncology agents: overcoming complexities of early-phase oncology trials for ATMPs

How to expedite clinical development of oncology agents: overcoming complexities of early-phase oncology trials for ATMPs

Harriet Gray Stephens
29 September
Viewpoint
Utilizing an automation-on-demand analytical tool for cancer immunotherapy

Utilizing an automation-on-demand analytical tool for cancer immunotherapy

Christoph Eberle
22 September
Innovator Insight
Harnessing chimeric antigen receptor (CAR)-T cells as a potential treatment for Alzheimer’s disease

Harnessing chimeric antigen receptor (CAR)-T cells as a potential treatment for Alzheimer’s disease

Lauren Sarko, Krishanu Saha
14 September
Expert Insight
View channel
View channel